First implantable pump kills brain cancer using chemo
European Pharmaceutical Review
NOVEMBER 16, 2022
A Phase I study published in the Lancet Oncology , demonstrated the first implantable pump system for patients with brain cancer , effectively killed recurrent glioblastoma (GBM) tumour cells by bypassing the blood-brain barrier to continuously deliver chemotherapy through a tube inserted directly into the brain.
Let's personalize your content